Toxicological aspects of feprazone, a new nonsteroidal anti-inflammatory drug-Reference-Cited by-同舟云学术

Toxicological aspects of feprazone, a new nonsteroidal anti-inflammatory drug

Published:1982-06 Issue:2 Volume:64 Page:255-270
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Koyama Tamotsu,Izawa Yoshihiro,Wada Hiroshi,Makita Tokutaro,Hashimoto Yoshinobu,Enomoto Makoto

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference20 articles.

1. Pharmacological investigation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). Part 3. General Pharmacological properties;Bianchi;Arzneim.-Forsch,1972

2. Pharmacological investigation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). Part 1. Anti-inflammatory, analgesic and antipyretic properties;Bianchi;Arzneim.-Forsch.,1972

3. Phenobarbital-induced fine structural changes in rat liver;Burger;Amer. J. Pathol.,1966

4. Terpene compounds as drugs x. 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370): A new anti-inflammatory drug, with low urcelogenic effects, derived from a series of terpenyl pyrazolidinediones;Casadio;Arzneim.-Forsch.,1972

5. Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). Part 1. Subacute and chronic toxicity in rats and dogs;Gaetani;Arzneim.-Forsch.,1972

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feprazone Ameliorates TNF-α-Induced Loss of Aggrecan via Inhibition of the SOX-4/ADAMTS-5 Signaling Pathway;ACS Omega;2021-03-12

2. Update of carcinogenicity studies in animals and humans of 535 marketed pharmaceuticals;Mutation Research/Reviews in Mutation Research;2012-01

3. Genotoxicity and carcinogenicity studies of analgesics, anti-inflammatory drugs and antipyretics;Pharmacological Research;2009-07